REMEDI Inc.

As of June 30, 2026, REMEDI Inc. has 7.63M shares outstanding.

As of June 30, 2026, REMEDI Inc. maintains a current ratio of 1.44, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, REMEDI Inc. recorded 760.82M in income tax expense. That works out to an effective tax rate of 29.04, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items.

These figures are as of the close on October 23, 2026.

These figures cover the twelve months ended June 30, 2026.

As of June 30, 2026, REMEDI Inc. holds 1.90B in cash and equivalents against 11.18B in total debt, resulting in a net debt position of 9.30B. Total book value stands at 15.73B, with working capital of 5.24B providing operational flexibility.

These figures cover the twelve months ended June 30, 2026. After subtracting -465.86M in capital expenditures, free cash flow totaled 2.68B - equivalent to 419.39 per share.

Over the twelve months ended June 30, 2026, REMEDI Inc. posted a gross margin of 70.97, reflecting its pricing power and cost economics. The operating margin of 45.81 and net profit margin of 30.16 provide insight into operational efficiency.